| Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies SC Ng, HY Shi, N Hamidi, FE Underwood, W Tang, EI Benchimol, ... The Lancet 390 (10114), 2769-2778, 2017 | 5782 | 2017 |
| Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis JKY Hooi, WY Lai, WK Ng, MMY Suen, FE Underwood, D Tanyingoh, ... Gastroenterology 153 (2), 420-429, 2017 | 3384 | 2017 |
| Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations JZ Liu, S Van Sommeren, H Huang, SC Ng, R Alberts, A Takahashi, ... Nature genetics 47 (9), 979-986, 2015 | 2660 | 2015 |
| Alterations in gut microbiota of patients with COVID-19 during time of hospitalization T Zuo, F Zhang, GCY Lui, YK Yeoh, AYL Li, H Zhan, Y Wan, ACK Chung, ... Gastroenterology 159 (3), 944-955. e8, 2020 | 1578 | 2020 |
| Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis R Mao, Y Qiu, JS He, JY Tan, XH Li, J Liang, J Shen, LR Zhu, Y Chen, ... The lancet Gastroenterology & hepatology 5 (7), 667-678, 2020 | 1297 | 2020 |
| Empagliflozin in patients with chronic kidney disease EMPA-Kidney Collaborative Group New England Journal of Medicine 388 (2), 117-127, 2023 | 1296 | 2023 |
| Understanding and preventing the global increase of inflammatory bowel disease GG Kaplan, SC Ng Gastroenterology 152 (2), 313-321. e2, 2017 | 1244 | 2017 |
| Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 YK Yeoh, T Zuo, GCY Lui, F Zhang, Q Liu, AYL Li, ACK Chung, ... Gut 70 (4), 698-706, 2021 | 1232 | 2021 |
| Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer J Yu, Q Feng, SH Wong, D Zhang, Q yi Liang, Y Qin, L Tang, H Zhao, ... Gut 66 (1), 70-78, 2017 | 1059 | 2017 |
| Mechanisms of action of probiotics: recent advances SC Ng, AL Hart, MA Kamm, AJ Stagg, SC Knight Inflammatory bowel diseases 15 (2), 300-310, 2009 | 982 | 2009 |
| Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study SC Ng, W Tang, JY Ching, M Wong, CM Chow, AJ Hui, TC Wong, ... Gastroenterology 145 (1), 158-165. e2, 2013 | 914 | 2013 |
| Crohn’s disease G Roda, S Chien Ng, PG Kotze, M Argollo, R Panaccione, A Spinelli, ... Nature Reviews Disease Primers 6 (1), 22, 2020 | 860 | 2020 |
| Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry EJ Brenner, RC Ungaro, RB Gearry, GG Kaplan, M Kissous-Hunt, ... Gastroenterology 159 (2), 481-491. e3, 2020 | 748 | 2020 |
| The global incidence of appendicitis: a systematic review of population-based studies M Ferris, S Quan, BS Kaplan, N Molodecky, CG Ball, GW Chernoff, ... Annals of surgery 266 (2), 237-241, 2017 | 715 | 2017 |
| Geographical variability and environmental risk factors in inflammatory bowel disease SC Ng, CN Bernstein, MH Vatn, PL Lakatos, EV Loftus, C Tysk, ... Gut 62 (4), 630-649, 2013 | 692 | 2013 |
| Gut mucosal microbiome across stages of colorectal carcinogenesis G Nakatsu, X Li, H Zhou, J Sheng, SH Wong, WKK Wu, SC Ng, H Tsoi, ... Nature communications 6 (1), 8727, 2015 | 675 | 2015 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 633* | 2021 |
| The epidemiology of inflammatory bowel disease: East meets west WY Mak, M Zhao, SC Ng, J Burisch Journal of gastroenterology and hepatology 35 (3), 380-389, 2020 | 594 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 573* | 2021 |
| The gut microbiota in the pathogenesis and therapeutics of inflammatory bowel disease T Zuo, SC Ng Frontiers in microbiology 9, 2247, 2018 | 559 | 2018 |
Francis K. L. ChanProfessor of Medicine, Dean, Faculty of Medicine, The Chinese University of Hong Kong在 cuhk.edu.hk 的电子邮件经过验证